Salvage therapy of refractory chronic disseminated candidiasis in a patient with acute myeloid leukaemia and secondary prophylaxis during allogeneic stem cell transplantation

Mycoses

Volumn 49, Issue SUPPL. 1, 2006, Pages 42-47

  Vehreschild, Jörg J ^a   Krüger, Karsten ^b   Kurzai, Oliver ^c   Wickenhauser, Claudia ^a   Behringer, Karolin ^a   Töx, Ulrich ^a   Cornely, Oliver A ^a,d  

^a UNIVERSITY OF COLOGNE   (Germany)

^b VIVANTES HOSPITAL   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Antifungal agents; Candidiasis; Drug resistance; Drug therapy; Mycoses; Triazoles

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; CYTARABINE; DAUNORUBICIN; FLUCONAZOLE; PLACEBO; POSACONAZOLE; TIOGUANINE; VANCOMYCIN; VORICONAZOLE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CANDIDIASIS; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; ESOPHAGUS CANDIDIASIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFECTION PREVENTION; LIVER BIOPSY; MALE; PRIORITY JOURNAL; SALVAGE THERAPY;

CANDIDA;

EID: 33748549633     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2006.01302.x     Document Type: Article

References (17)

1. Banerjee SN, Emori TG, Culver DH et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. Am J Med 1991; 91: 86S-89S.
2. Beck-Sague C, Jarvis WR. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. J Infect Dis 1993; 167: 1247-51.
3. Reichenspurner H, Gamberg P, Nitschke M et al. Significant reduction in the number of fungal infections after lung-, heart-lung, and heart transplantation using aerosolized amphotericin B prophylaxis. Transplant Proc 1997; 29: 627-8.
4. Morrison AJ Jr, Freer CV, Searcy MA et al. Nosocomial bloodstream infections: secular trends in a statewide surveillance program in Virginia. Infect Control 1986; 7: 550-3.
5. Bow EJ. Long-term antifungal prophylaxis in high-risk hematopoietic stem cell transplant recipients. Med Mycol 2005; 43(Suppl 1): S277-87.
6. Bow EJ, Laverdiere M, Lussier N et al. Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials. Cancer 2002; 94: 3230-46.
7. Cornely OA, Maertens J, Winston D. Posaconazole vs standard azole therapy for prophylaxis of invasive fungal infections among high-risk neutropenic patients: results of a randomized, multicenter trial. In: 47th Annual Meeting of the American Society of Hematology, Atlanta, USA, 2005.
8. Abe F, Tateyama M, Shibuya H et al. Disseminated fungal infection. A review of 20 autopsy cases. Acta Pathol Jpn 1984; 34: 1201-8.
9. Bodey G, Bueltmann B, Duguid W et al. Fungal infections in cancer patients: an international autopsy survey. Eur J Clin Microbiol Infect Dis 1992; 11: 99-109.
10. Cho SY, Choi HY. Opportunistic fungal infection among cancer patients. A ten-year autopsy study. Am J Clin Pathol 1979; 72: 617-21.
11. Jandrlic M, Kalenic S, Labar B et al. An autopsy study of systemic fungal infections in patients with hematologic malignancies. Eur J Clin Microbiol Infect Dis 1995; 14: 768-74.
12. Pagano L, Mele L, Fianchi L et al. Chronic disseminated candidiasis in patients with hematologic malignancies. Clinical features and outcome of 29 episodes. Haematologica 2002; 87: 535-41.
13. Masood A, Sallah S. Chronic disseminated candidiasis in patients with acute leukemia: emphasis on diagnostic definition and treatment. Leuk Res 2005; 29: 493-501.
14. Keating GM. Posaconazole. Drugs 2005; 65: 1553-67; discussion: 1568-9.
15. Dodds Ashley ES, Alexander BD. Posaconazole. Drugs Today (Barc) 2005; 41: 393-400.
16. Ascioglu S, Rex JH, de Pauw B et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7-14.
17. Deresinski SC, Stevens DA. Caspofungin. Clin Infect Dis 2003; 36: 1445-57.